Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

BYN 001

Next Previous
Drug Profile

BYN 001

Alternative Names: Anti-IL25 monoclonal antibody; BYN-001; IL25 targeting monoclonal antibody; Interleukin-25 targeting monoclonal antibody - NovaRock Biotherapeutics; NBL-023

Latest Information Update: 12 Aug 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator NovaRock Biotherapeutics
  • Developer Bionyra Pharma; NovaRock Biotherapeutics
  • Class Anti-inflammatories; Antiasthmatics; Monoclonal antibodies; Skin disorder therapies
  • Mechanism of Action Interleukin 17 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Atopic dermatitis; Inflammation
  • Research Asthma

Most Recent Events

  • 07 Aug 2026 Bionyra Pharma plans a phase I trial for Atopic dermatitis in August 2026 (SC, injection) (NCT07746817)
  • 22 Jun 2026 BYN-001 licensed to Bionyra Pharma worldwide except Greater China which includes China, Hong Kong, Macau, Taiwan
  • 22 Jun 2026 Preclinical trials in Atopic dermatitis in USA (Parenteral)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top